Myrmecia pilosula (Jack Jumper) ant venom: Identification of allergens and revised nomenclature

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 62, Issue 4, 2007, Pages 437-443

  Wiese, M D ^a,b,c,d   Brown, S G A ^a,e,f   Chataway, T K ^g   Davies, N W ^h   Milne, R W ^b   Aulfrey, S J ^e,f   Heddle, R J ^c,g  

^a ROYAL HOBART HOSPITAL   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c FLINDERS MEDICAL CENTRE   (Australia)

^d UNIVERSITY OF TASMANIA   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^g FLINDERS UNIVERSITY   (Australia)

^h UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Myr p 1; Myr p 2; Myr p 3; Myrmecia pilosula (Jack Jumper) ant venom; Pilosulin

Indexed keywords

ALLERGEN; ANT VENOM; IMMUNOGLOBULIN BINDING FACTOR; IMMUNOGLOBULIN E; PILOSULIN 1 [5 ISOLEUCINE]; PILOSULIN 3; PILOSULIN 4.1; UNCLASSIFIED DRUG;

ADULT; ALLERGENICITY; ANAMNESIS; ANAPHYLAXIS; ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HUMAN; INSECT STING; MALE; MOLECULAR PROBE; MOLECULAR WEIGHT; NOMENCLATURE; PRIORITY JOURNAL; PROTEIN BINDING; RADIOALLERGOSORBENT TEST; WESTERN BLOTTING;

ADOLESCENT; ADULT; ALLERGENS; ANIMALS; ANT VENOMS; ANTS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; MIDDLE AGED; RADIOALLERGOSORBENT TEST; TERMINOLOGY;

EID: 33947114416     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2007.01320.x     Document Type: Article

References (25)

1. Brown SG, Franks RW, Baldo BA, Heddle RJ. Prevalence, severity, and natural history of Jack Jumper ant venom allergy in Tasmania. J Allergy Clin Immunol 2003;111:187-192.
2. Douglas RG, Weiner JM, Abramson MJ, O'Hehir RE. Prevalence of severe ant-venom allergy in southeastern Australia. J Allergy Clin Immunol 1998;101:129-131.
3. Street MD, Donovan GR, Baldo BA, Sutherland S. Immediate allergic reactions to Myrmecia ant stings: immunochemical analysis of Myrmecia venoms. Clin Exp Allergy 1994;24:590-597.
4. Brown SG, Wiese MD, Blackman KE, Heddle RJ. Ant venom immunotherapy: a double-blind, placebo-controlled, crossover trial. Lancet 2003;361:1001- 1006.
5. Wiese MD, Chataway TK, Davies NW, Milne RW, Brown SG, Gai WP et al. Proteomic analysis of Myrmecia pilosula (Jack Jumper) ant venom. Toxicon 2006;47:208-217.
6. Donovan GR, Street MD, Tetaz T, Smith AL, Alewood D, Alewood P et al. Expression of jumper ant (Myrmecia pilosula) venom allergens: post-translational processing of allergen gene products. Biochem Mol Biol Int 1996;39:877-885.
7. Donovan GR, Baldo BA, Sutherland S. Molecular cloning and characterization of a major allergen (Myr p I) from the venom of the Australian jumper ant, Myrmecia pilosula. Biochim Biophys Acta 1993;1171:272- 280.
8. Street MD, Donovan GR, Baldo BA. Molecular cloning and characterization of the major allergen Myr p II from the venom of the jumper ant Myrmecia pilosula: Myr p I and Myr p II share a common protein leader sequence. Biochim Biophys Acta 1996;1305:87-97.
9. Wu QX, King MA, Donovan GR, Alewood D, Alewood P, Sawyer WH et al. Cytotoxicity of pilosulin 1, a peptide from the venom of the jumper ant Myrmecia pilosula. Biochim Biophys Acta 1998;1425:74-80.
10. Davies NW, Wiese MD, Brown SG. Characterisation of major peptides in 'Jack Jumper' ant venom by mass spectrometry. Toxicon 2004;43:173-183.
11. Inagaki H, Akagi M, Imai HT, Taylor RW, Kubo T. Molecular cloning and biological characterization of novel antimicrobial peptides, pilosulin 3 and pilosulin 4, from a species of the Australian ant genus Myrmecia. Arch Biochem Biophys 2004;428:170-178.
12. Brown SG, Wu QX, Kelsall GR, Heddle RJ, Baldo BA. Fatal anaphylaxis following jack jumper ant sting in southern Tasmania. Med J Aust 2001;175:644-647.
13. Wu QX. Immunobiology of peptides of the Jumper Ant Myrmecia pilosula. PhD thesis, University of Sydney, Sydney, 2000.
14. King TP, Hoffman D, Lowenstein H, Marsh DG, Platts-Mills TA, Thomas W. Allergen nomenclature. Allergy 1995;50:765-774.
15. Wang MS, Pang JS, Selsted ME. Semidry electroblotting of peptides and proteins from acid-urea polyacrylamide gels. Anal Biochem 1997;253:225- 230.
16. Schagger H, von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 1987;166:368-379.
17. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979;76:4350-4354.
18. Swerdlow PS, Finley D, Varshavsky A. Enhancement of immunoblot sensitivity by heating of hydrated filters. Anal Biochem 1986;156:147- 153.
19. Ida N, Hartmann T, Pantel J, Schroder J, Zerfass R, Forstl H et al. Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay. J Biol Chem 1996;271: 22908-22914.
20. Donovan GR, Street MD, Baldo BA. Separation of jumper ant (Myrmecia pilosula) venom allergens: a novel group of highly basic proteins. Electrophoresis 1995;16:804-810.
21. Paull BR, Yunginger JW, Gleich GJ. Melittin: an allergen of honeybee venom. J Allergy Clin Immunol 1977;59:334-338.
22. Kettner A, Hughes GJ, Frutiger S, Astori M, Roggero M, Spertini F et al. Api m 6: a new bee venom allergen. J Allergy Clin Immunol 2001;107:914- 920.
23. King T, Guralnick M. Hymenoptera allergens. In: Lockey R, Bukantz S, Bousquet J, editors. Allergens and allergen immunotherapy, 3rd edn. New York: Marcel Dekker, 2004:339-354.
24. Muller UR. Recombinant Hymenoptera venom allergens. Allergy 2002;57:570-576.
25. Muller U. Insect sting allergy: clinical picture, diagnosis, and treatment. New York: Gustav Fischer Verlag, 1990.